Table 2.
Baseline (n = 49) | Final treatment (n = 49) | Difference | p value* | |
---|---|---|---|---|
Systolic BP (mmHg) | 134.5 (126.8–144.0) | 127.5 (119.3–134.0) | 8.5 (5.0 to 13.3) | <0.001 |
Diastolic BP (mmHg) | 83.5 (79.0–91.3) | 76.0 (70.0–81.3) | 8.0 (5.0 to 12.0) | <0.001 |
Glucose (mmol/l) | 8.53 (7.26–10.56) | 7.32 (6.52–9.85) | 0.55 (0.47 to 1.82) | 0.026 |
BUN (mmol/l) | 6.06 (4.99–7.13) | 4.64 (3.92–6.06) | 1.07 (0.53 to 2.14) | 0.020 |
CT (µmol/l) | 97.24 (79.56–114.92) | 79.56 (70.72–88.4) | 8.84 (8.84 to 0.40) | 0.003 |
eGFR (ml/min/1.73 m2) | 59.61 (49.70–80.99) | 70.96 (64.12–92.97) | −6.85 (−25.98 to 9.36) | <0.001 |
Total cholesterol (mmol/l) | 4.26 (3.56–4.77) | 4.28 (3.73–5.03) | −0.15 (−0.89 to 0.31) | 0.120 |
Triglyceride (mmol/l) | 1.32 (1.02–2.27) | 1.20 (0.79–1.70) | 0.32 (−0.05 to 0.95) | 0.001 |
HDL-C (mmol/l) | 1.22 (1.01–1.44) | 1.50 (1.24–1.75) | −0.26 (−0.36 to −0.12) | <0.001 |
LDL-C (mmol/l) | 2.19 (1.63–2.61) | 2.22(1.86–2.73) | −0.18 (−0.69 to 0.34) | 0.100 |
TG/HDL-C ratio | 2.71 (1.57–5.25) | 1.93 (1.15–3.01) | 0.95 (0.18 to 2.02) | <0.001 |
HbA1c (mmol/mol) | 63.9 (57.4–80.9) | 59.6 (50.8–71.0) | 0.9 (0.0 to 1.3) | <0.001 |
* Wilcoxon signed-rank tests